Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Zibo Meng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6690-7380; OpenAlex author ID A5060391016. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2019: 3 papers · 2020: 4 papers · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 11

  1. [Implementation of personalized T-cell therapy in the treatment of pancreatic cancer]. First author DOI 10.3760/cma.j.cn112139-20250328-00164↗
  2. Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer. Co-author DOI 10.1126/scitranslmed.adh9562↗
  3. Correction for: Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pan… Co-author DOI 10.18632/aging.205456↗
  4. Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway. Co-author DOI 10.1016/j.jcmgh.2022.07.008↗
  5. The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients. Co-author DOI 10.1016/j.omto.2020.04.011↗
  6. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocar… Co-author DOI 10.18632/aging.102931↗
  7. The aberrant expression of ADAR1 promotes resistance to BET inhibitors in pancreatic cancer by stabilizing c-Myc. Co-author PMID 32064158↗
  8. FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression. Co-author PMID 32195024↗
  9. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.biocel.2019.01.011↗
  10. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis. Co-author DOI 10.1186/s12876-019-0975-3↗
  11. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer. Co-author DOI 10.1186/s13046-019-1044-z↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 9 shared papers, 2019–2023 · strength 1.19
  2. Jingyuan Zhao · 7 shared papers, 2019–2023 · strength 0.90
  3. Xin Jin · 7 shared papers, 2019–2023 · strength 0.90
  4. Rienk Offringa · 3 shared papers, 2020–2025 · strength 0.56
  5. Dianyun Ren · 3 shared papers, 2020–2023 · strength 0.46
  6. Shihong Wu · 3 shared papers, 2019–2022 · strength 0.36
  7. Kun Zhang · 2 shared papers, 2020–2023 · strength 0.34
  8. Ping Fan · 3 shared papers, 2019–2020 · strength 0.32
  9. Hongsheng Wu · 1 shared paper, 2025 · strength 0.30
  10. Chong Yang · 2 shared papers, 2019–2020 · strength 0.21
  11. Zhiqiang Liu · 2 shared papers, 2019 · strength 0.21
  12. Jiaoshun Chen · 1 shared paper, 2022 · strength 0.15
  13. Tao Yin · 1 shared paper, 2022 · strength 0.15
  14. Hehe Li · 1 shared paper, 2022 · strength 0.15
  15. Haoxiang Zhang · 1 shared paper, 2022 · strength 0.15
  16. Michael Volkmar · 1 shared paper, 2023 · strength 0.14
  17. Isabel C. Poschke · 1 shared paper, 2023 · strength 0.14
  18. Carl-Stephan Leonhardt · 1 shared paper, 2023 · strength 0.14
  19. Oliver Strobel · 1 shared paper, 2023 · strength 0.14
  20. Shikai Zhu · 1 shared paper, 2020 · strength 0.12
  21. Yan Ping Sun · 1 shared paper, 2020 · strength 0.11
  22. Bo Wang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.